In the last few years, the identification of individuals carriers of inactivating mutations on BRCA1 and 2 genes has been essentially directed to cancer prevention by the use of prophylactic surgery [38,39], preventive treatments or screening procedures different from general population [40-43]. The gene discussed is BRCA1; the disease is cancer.